|
Volumn 49, Issue 5, 2001, Pages 1275-1279
|
Paclitaxel and concurrent radiation for locally advanced pancreatic cancer
a,c a a a a a a a a a a a b a |
Author keywords
Paclitaxel; Pancreatic cancer; Radiotherapy
|
Indexed keywords
PANCREATIC CANCERS;
PATIENT MONITORING;
PATIENT TREATMENT;
RADIATION;
TUMORS;
TOXICITY;
DEXAMETHASONE;
DIPHENHYDRAMINE;
MARIMASTAT;
PACLITAXEL;
RANITIDINE;
ADULT;
ADVANCED CANCER;
AGED;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG INFUSION;
FEMALE;
HUMAN;
HYPERSENSITIVITY REACTION;
INOPERABLE CANCER;
MALE;
NAUSEA AND VOMITING;
NEUTROPENIA;
PANCREAS ADENOCARCINOMA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RADIATION DOSE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CONFIDENCE INTERVALS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PANCREATIC NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
SURVIVAL ANALYSIS;
|
EID: 0035312196
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(00)01527-3 Document Type: Conference Paper |
Times cited : (64)
|
References (21)
|